Concepedia

Author

Brigid C. Browne

Dublin City University

Also Known As

B Browne, B C Browne, B. Browne, B. C. Browne, B.C. Browne, Brigid Browne, Brigid C Browne, Brigid C. Browne

86

Publications

1.3K

Citations

16

H-Index

29

Concepts

All Affiliations

Dublin City UniversitySt. Vincent's University HospitalUniversity of California, Los AngelesUniversity College DublinGarvan Institute of Medical Research
BC

About

Brigid C. Browne is an author at Dublin City University specializing in medicine, tumor biology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

941

2

Cell Biology

9

9

877

3

Pharmacology

3

3

112

4

Cellular Physiology

1

1

25

5

Pathology

1

1

37

Brigid C. Browne

×

15

Publications

1.1K

Citations

15

H-Index

YearCitations

Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib

Neil A. O’Brien, Brigid C. Browne, Lucy Chow,

Molecular Cancer Therapeutics

2010

334

Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells

Falko Hochgräfe, Luxi Zhang, Sandra O’Toole,

Cancer Research

2010

170

Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells

Brigid C. Browne, John Crown, Natarajan Venkatesan,

Annals of Oncology

2010

98

Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway

David R. Croucher, Falko Hochgräfe, Luxi Zhang,

Cancer Research

2013

91

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

Bríd M. Ryan, Norma O’Donovan, Brigid C. Browne,

British Journal of Cancer

2004

91

Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors

Sweta Rani, Claire Corcoran, Liam Shiels,

Cancer Research

2014

44

PP2A inhibition overcomes acquired resistance to HER2 targeted therapy

Martina S.J. McDermott, Brigid C. Browne, Neil T. Conlon,

Molecular Cancer

2014

42

Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells

Martina S.J. McDermott, Alexandra Canonici, Laura Ivers,

International Journal of Oncology

2017

39

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells

Martina S.J. McDermott, Neil T. Conlon, Brigid C. Browne,

Cancers

2019

39

Global characterization of signalling networks associated with tamoxifen resistance in breast cancer

Brigid C. Browne, Falko Hochgräfe, Jianmin Wu,

FEBS Journal

2013

37

Page 1